Current Report Filing (8-k)
August 04 2021 - 5:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 29, 2021
|
BALANCE
LABS, INC.
|
|
|
(Exact
name of registrant as specified in charter)
|
|
Delaware
|
|
333-202959
|
|
47-1146785
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
350
Lincoln Road, 4th Floor, Beach, Florida 33139
(Address
of Principal Executive Offices) (Zip Code)
(305)
907-7600
(Registrant’s
Telephone Number, Including Area Code)
Not
Applicable
(Former
Name or Former Address, If Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.0001 per shares
|
|
BLNC
|
|
OTC
Markets Group
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
2.01. Completion of Acquisition or Disposition of Assets.
On
June 15, 2021, (the “Effective Date”), a majority owned subsidiary of Balance Labs, Inc. (the “Company”), Krypto
Ventures Inc. (formerly KryptoBank Co.), a Delaware corporation (“Krypto Ventures”), entered into a share exchange agreement
(the “Share Exchange Agreement”) with (i) W Technologies, Inc., a Delaware corporation (“W Tech”), (ii) each
of the stockholders of Krypto Ventures (the “Krypto Ventures Stockholders”) and (iii) Aleksandr Rubin as the representative
of the Krypto Ventures Stockholders (the “Stockholders’ Representative”). As a result of the Exchange, the Company
now owns 46.1% of the issued and outstanding common stock of W Tech and the Company no longer owns any portion of Krypto Ventures
Inc. outstanding common stock.
The
Closing of the Share Exchange Agreement occurred on July 29, 2021. Pursuant to the terms of the Share Exchange Agreement, W Tech acquired
102,500,000 shares of Krypto Ventures’ common stock, representing 100% of the issued and outstanding capital stock of Krypto Ventures,
in exchange for the issuance to the Krypto Ventures Stockholders of 233,474,958 shares of the W Tech’s common stock (the “Exchange”).
Immediately prior to the closing of the Share Exchange Agreement, the Company owned 52,500,000 shares of common stock of Krypto Ventures
which it exchanged for 119,584,736 shares of common stock of W Tech.
In connection
with the transaction, the Company entered into a lockup agreement pursuant to which the Company agreed, among other things, that they
will not sell or transfer (subject to certain customary exceptions) any shares of the W Tech’s Common Stock for a period of 12
months following the Closing, and also agreed not to (i) offer for sale, sell, pledge or otherwise dispose of (or enter into any transaction
or device that is designed to, or could be expected to, result in the disposition by any person at any time in the future of) any shares
of the W Tech’s Common Stock; (ii) enter into any swap or other derivatives transaction that transfers to another, in whole or
in part, any of the economic benefits or risks of ownership of shares of the W Tech’s Common Stock, whether any such transaction
is to be settled by delivery of shares of the W Tech’s Common Stock or other securities, in case or otherwise; or (iii) publicly
disclose the intention to do any of the foregoing actions.
Item
9.01.Financial Statements and Exhibits.
|
(a)
|
Financial statements
of business acquired.
|
The
financial statements that may be required in connection with the closing of the Exchange Agreement are not included in this Current Report
on Form 8-K. The Company will file any required financial statements within 71 calendar days after the date this Current Report on Form
8-K was required to be filed with the Securities and Exchange Commission.
|
(b)
|
Pro forma financial
information.
|
The
financial statements that may be required in connection with the closing of the Exchange Agreement are not included in this Current Report
on Form 8-K. The Company will file any required financial statements within 71 calendar days after the date this Current Report on Form
8-K was required to be filed with the Securities and Exchange Commission.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Balance
Labs, Inc.
|
Date:
August 4 2021
|
|
|
|
|
/s/
Michael D. Farkas
|
|
Name:
|
Michael
D. Farkas
|
|
Title:
|
Chief
Executive Officer
|
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Nov 2024 to Dec 2024
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Dec 2023 to Dec 2024